Related Experiment Videos
Immunological response to stress in agoraphobia and panic attacks
Biological Psychiatry
|July 1, 1986
Summary
This study found no difference in immune function between patients with panic attacks and healthy individuals. Immune status, measured by lymphocyte response, remained unchanged in anxiety disorder patients during a psychopharmacological trial.
Area of Science:
- Psychoneuroimmunology
- Anxiety Disorders
- Clinical Psychology
Background:
- Anxiety disorders, such as panic attacks, are prevalent and can impact overall health.
- The relationship between psychological stress and immune system function is an area of ongoing research.
- Previous studies have suggested potential links between immune status and mental health conditions.
Purpose of the Study:
- To investigate in vitro immune function in patients diagnosed with agoraphobia and panic attacks.
- To compare the immune status of patients with anxiety disorders to that of healthy controls.
- To assess immune response during a psychopharmacological intervention for anxiety.
Main Methods:
- Immune function was assessed using the lymphocytic proliferative response to mitogen stimulation.
- A double-blind, placebo-controlled design was employed for the psychopharmacological study.
- The study included 36 patients with agoraphobia and panic attacks and a control group.
Main Results:
- No statistically significant differences were observed in immune status between patients with panic attacks and healthy controls.
- Lymphocytic proliferative response to mitogen stimulation did not differ between the groups.
- Immune function remained comparable between the patient and control groups throughout the study.
Conclusions:
- The findings suggest that panic disorder and agoraphobia, in this cohort, are not associated with significant alterations in cellular immune function.
- Immune status, as measured by lymphocyte proliferation, does not appear to be compromised in patients with anxiety disorders.
- Further research is warranted to explore the complex interplay between anxiety, psychopharmacological treatments, and the immune system.